CIK 0001527352
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Nexalin Technology, Inc.
Sign in to watch- Ticker
- NXL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275566468
- Phone
- +1 832-260-0222
- Business address
- 1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $3.10 ($3,100)
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $2.98 ($2,980)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Chief Medical Officer bought 1,500 shares at $2.70 ($4,050)
- 4 Open-market buy Chief Medical Officer bought 3,000 shares at an average $2.57 ($7,700)
- 4 Open-market buy Chief Medical Officer bought 500 shares at $2.19 ($1,095)
- 4/A Grant or award 10% owner acquired 700,000 shares (grant or award)
- 4 Grant or award Director acquired 49,838 shares (grant or award)
- 4 Grant or award Director acquired 175,000 shares (grant or award)
- 4 Grant or award 10% owner acquired 700,000 shares (grant or award)
- 4/A Derivatives Options or other derivatives
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $0.95 ($950)
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $1.75 ($1,750)
- 4 Open-market buy Chief Medical Officer bought 1,619 shares at $0.71 ($1,149)
- 4 Open-market buy Chief Medical Officer bought 3,000 shares at an average $0.64 ($1,920)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 3 · 58 filings